Drug Shortage Report for NAROPIN
| Report ID | 149197 |
| Drug Identification Number | 02229418 |
| Brand name | NAROPIN |
| Common or Proper name | ropivacaine HCl 10mg/mL 5x20mL SU Polyamp® Duofit® |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | EPIDURAL EPIDURAL |
| Packaging size | 50 PE Polyamp |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-03-15 |
| Actual start date | 2022-03-03 |
| Estimated end date | 2022-04-15 |
| Actual end date | 2022-04-06 |
| Shortage status | Resolved |
| Updated date | 2022-04-19 |
| Company comments | VR89864CA1 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2021-12-22 | English | Compare |
| v2 | 2021-11-12 | French | Compare |
| v1 | 2021-11-12 | English | Compare |